Laura Klasen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Laura Klasen has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Laura De Laporte
DWI – Leibniz Institute for Interactive Materials
4 shared publications - Aaron Babendreyer
Institute of Molecular Pharmacology, University Hospital RWTH Aachen, Aachen, Germany
2 shared publications - Jacopo Di Russo
Institute of Molecular and Cellular Anatomy, RWTH Aachen University, Germany
2 shared publications - Kira Zeevaert
Helmholtz‐Institute for Biomedical Engineering RWTH Aachen University Aachen Germany
2 shared publications - Matthias Mork
DWI-Leibniz Institute for Interactive Materials e. V. Forckenbeckstraße 50 52074 Aachen Germany
2 shared publications - Ramin Nasehi
Institute For Technical and Macromolecular Chemistry RWTH Aachen University Aachen Germany
2 shared publications
Latest Publications
- Open Access
- 23 September 2026
- Published by Wiley in Advanced Materials
Microgels Enable iPSCs to Assemble, Expand, and Differentiate Into Organoids—From Sizable to High‐Throughput
Organoid research holds tremendous potential for personalized medicine and drug development. However, current limitations include reproducibility issues largely due to the use of biologically derived materials, which are prone to batch‐to‐batch variations. Here, we report a chemically defined microgel‐based method for human induced pluripotent stem cell (iPSC)‐based organoid generation, enabling expansion of iPSCs and their subsequent differentiation within one construct across different scales, including compatibility with automated 384‐well plate workflows. Chemically defined poly(ethylene glycol) (PEG)‐based microgels are produced via parallelized step‐emulsification microfluidics, enabling scalable production. This approach leverages the self‐organization of iPSCs with microgels to build three‐dimensional constructs, driven by robust cell‐material interactions achieved through vitronectin‐coated PEG microgels. This technology allows the iPSCs to expand and retain their pluripotency, after which they can be differentiated into the three germ layers, providing a suitable platform for organoid differentiation. This was further extended by differentiation into cardiac organoids and retinal photoreceptors to demonstrate two exemplary tissues.
- 23 September 2026
- Published by Wiley in Advanced Materials
Open AccessMicrogels Enable iPSCs to Assemble, Expand, and Differentiate Into Organoids—From Sizable to High‐Throughput
Organoid research holds tremendous potential for personalized medicine and drug development. However, current limitations include reproducibility issues largely due to the use of biologically derived materials, which are prone to batch‐to‐batch variations. Here, we report a chemically defined microgel‐based method for human induced pluripotent stem cell (iPSC)‐based organoid generation, enabling expansion of iPSCs and their subsequent differentiation within one construct across different scales, including compatibility with automated 384‐well plate workflows. Chemically defined poly(ethylene glycol) (PEG)‐based microgels are produced via parallelized step‐emulsification microfluidics, enabling scalable production. This approach leverages the self‐organization of iPSCs with microgels to build three‐dimensional constructs, driven by robust cell‐material interactions achieved through vitronectin‐coated PEG microgels. This technology allows the iPSCs to expand and retain their pluripotency, after which they can be differentiated into the three germ layers, providing a suitable platform for organoid differentiation. This was further extended by differentiation into cardiac organoids and retinal photoreceptors to demonstrate two exemplary tissues.
- Open Access
Differentiation and maturation of iPSC-derived motor and sensory neurospheres using biomodified PEG-based microgels
Sensory and motor neurons differ significantly in their morphology, structural organization, functional properties, and mode of action. However, despite this heterogeneity, many in vitro studies focus only on a single neuronal subtype, mainly being sensory neurons, limiting the translational potential and relevance of these studies for the evaluation of therapeutic options for spinal cord injury. In this study, we investigate the differentiation, maturation, and neuronal outgrowth of human induced pluripotent stem cell (iPSC)-derived motor and sensory neurospheres using polyethylene glycol (PEG)-microgels with various bioactive coatings. Our results show subtype-specific responses to the PEG-microgel scaffolds, with respect to motor and sensory neurosphere morphology and size. Furthermore, we compare the formation of the PEG-microgel/scaffolds when starting from iPSCs-derived precursor neuron spheres versus undifferentiated iPSCs. We observe notable differences in structural organization, maturity, and neuronal outgrowth between the two approaches, as well as between motor and sensory neurospheres. Together, these results underline the importance of studying motor and sensory neurons separately and highlight the need for a controlled, tunable culture platform to assess the impact of the microenvironment and to improve the physiological relevance of in vitro platforms for neuron-based research.
Open AccessDifferentiation and maturation of iPSC-derived motor and sensory neurospheres using biomodified PEG-based microgels
Sensory and motor neurons differ significantly in their morphology, structural organization, functional properties, and mode of action. However, despite this heterogeneity, many in vitro studies focus only on a single neuronal subtype, mainly being sensory neurons, limiting the translational potential and relevance of these studies for the evaluation of therapeutic options for spinal cord injury. In this study, we investigate the differentiation, maturation, and neuronal outgrowth of human induced pluripotent stem cell (iPSC)-derived motor and sensory neurospheres using polyethylene glycol (PEG)-microgels with various bioactive coatings. Our results show subtype-specific responses to the PEG-microgel scaffolds, with respect to motor and sensory neurosphere morphology and size. Furthermore, we compare the formation of the PEG-microgel/scaffolds when starting from iPSCs-derived precursor neuron spheres versus undifferentiated iPSCs. We observe notable differences in structural organization, maturity, and neuronal outgrowth between the two approaches, as well as between motor and sensory neurospheres. Together, these results underline the importance of studying motor and sensory neurons separately and highlight the need for a controlled, tunable culture platform to assess the impact of the microenvironment and to improve the physiological relevance of in vitro platforms for neuron-based research.
- Open Access
Structural guidance in 3D microgel-in-hydrogel systems to improve chondrogenesis
Anisotropic biomaterials are broadly studied in regenerative medicine as they aim to mimic the hierarchical structures of native tissue. The Anisogel, an anisotropic microgel-in-hydrogel system, involves two key factors for tissue engineering: guidance cues – magnetically aligned rod-shape structures - and a surrounding matrix - polyethylene glycol-vinylsulfone (PEG-VS) with a degradable peptide crosslinker. This research shows the potential of using a PEG-VS-based Anisogel to allow for guided ingrowth and chondrogenic differentiation of human mesenchymal stromal cells (hMSCs) modulated by the alignment and size of anisometric microgels. The properties of the surrounding matrix are optimized for the availability of anchoring peptides (RGD concentration) and matrix density (hydrogel precursor concentration). The microgels of highest tested dimensions (10×10×100 µm 3 ) lead to a donor-independent significant upregulation of chondrogenic markers ( SOX 9 , ACAN and COL2AI ) and a decrease of hypertrophic chondrogenic markers ( RUNX 2 ), compared to unaligned and smaller microgel sizes. As a proof of concept, the Anisogel is tested in a semi-orthotopic mouse model where the effect of microgel alignment on cell infiltration and osteochondral tissue formation is evaluated.
Open AccessStructural guidance in 3D microgel-in-hydrogel systems to improve chondrogenesis
Anisotropic biomaterials are broadly studied in regenerative medicine as they aim to mimic the hierarchical structures of native tissue. The Anisogel, an anisotropic microgel-in-hydrogel system, involves two key factors for tissue engineering: guidance cues – magnetically aligned rod-shape structures - and a surrounding matrix - polyethylene glycol-vinylsulfone (PEG-VS) with a degradable peptide crosslinker. This research shows the potential of using a PEG-VS-based Anisogel to allow for guided ingrowth and chondrogenic differentiation of human mesenchymal stromal cells (hMSCs) modulated by the alignment and size of anisometric microgels. The properties of the surrounding matrix are optimized for the availability of anchoring peptides (RGD concentration) and matrix density (hydrogel precursor concentration). The microgels of highest tested dimensions (10×10×100 µm 3 ) lead to a donor-independent significant upregulation of chondrogenic markers ( SOX 9 , ACAN and COL2AI ) and a decrease of hypertrophic chondrogenic markers ( RUNX 2 ), compared to unaligned and smaller microgel sizes. As a proof of concept, the Anisogel is tested in a semi-orthotopic mouse model where the effect of microgel alignment on cell infiltration and osteochondral tissue formation is evaluated.
- Open Access
Microgels enable iPSCs to assemble, expand, and differentiate into organoids – from sizable to high throughput
Organoid research holds tremendous potential for personalized medicine and drug development. However, current limitations include reproducibility issues largely due to the use of biologically derived materials, which are prone to batch-to-batch variations. Here, we report a new technology for human induced pluripotent stem cell (iPSC)-based organoid production with iPSC expansion and differentiation in the same construct in a reproducible and scalable manner, compatible with high-throughput automation. Chemically defined poly(ethylene glycol) (PEG)-based microgels are produced via parallelized step-emulsification microfluidics, enabling scalable production. This approach leverages the self-organization of iPSCs with microgels to build three-dimensional constructs, driven by robust cell-material interactions achieved through vitronectin-coated PEG microgels. This technology allows the iPSCs to expand and retain their pluripotency, after which they can be differentiated into the three germ layers, providing a suitable platform for organoid differentiation. This was further extended by differentiation into cardiac organoids and retinal photoreceptors to demonstrate two exemplary tissues.
Open AccessMicrogels enable iPSCs to assemble, expand, and differentiate into organoids – from sizable to high throughput
Organoid research holds tremendous potential for personalized medicine and drug development. However, current limitations include reproducibility issues largely due to the use of biologically derived materials, which are prone to batch-to-batch variations. Here, we report a new technology for human induced pluripotent stem cell (iPSC)-based organoid production with iPSC expansion and differentiation in the same construct in a reproducible and scalable manner, compatible with high-throughput automation. Chemically defined poly(ethylene glycol) (PEG)-based microgels are produced via parallelized step-emulsification microfluidics, enabling scalable production. This approach leverages the self-organization of iPSCs with microgels to build three-dimensional constructs, driven by robust cell-material interactions achieved through vitronectin-coated PEG microgels. This technology allows the iPSCs to expand and retain their pluripotency, after which they can be differentiated into the three germ layers, providing a suitable platform for organoid differentiation. This was further extended by differentiation into cardiac organoids and retinal photoreceptors to demonstrate two exemplary tissues.